Stock Price
0.90
Daily Change
0.01 0.63%
Monthly
-6.50%
Yearly
-22.46%
Q2 Forecast
0.88

Standard Biotools reported $108.31M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Agilent USD 2.23B 113M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
Bruker USD 1.28B 11.1M Dec/2025
Danaher USD 7.46B 653M Mar/2026
Illumina USD 1.59B 377M Dec/2025
Myriad Genetics USD 133.8M 14.2M Dec/2025
Nikon Corporation JPY 368.38B 30.3B Dec/2025
Pacific Biosciences Of California USD 72.83M 9.62M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sony JPY 5.16T 20.87T Dec/2025
Standard Biotools USD 108.31M 343K Dec/2025
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Waters USD 1.24B 11.8M Dec/2025